Eric K. Rowinsky - 05 Sep 2017 Form 4 Insider Report for Verastem, Inc. (VSTM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Jan 2024, 16:00:39 UTC
Next SEC filing
30 Jun 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Eric Rowinksy

Key filing fact

Eric K. Rowinsky filed Form 4 for Verastem, Inc. (VSTM) on 24 Jan 2024.

Key facts

  • This page summarizes Eric K. Rowinsky's Form 4 filing for Verastem, Inc. (VSTM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 24 Jan 2024, 16:00.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: +$7,680.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VSTM transaction

Common Stock

Purchase

Transaction value
$7,680
Shares
+2,000
Change %
Price
$3.84*
Shares after
2,000
Date
05 Sep 2017
Ownership
By spouse
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

In connection with recent divorce proceedings, Dr. Rowinsky learned of the purchase of Verastem, Inc. securities by his spouse, Lisa Slater, on September 5, 2017.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .